Showing results (101-110 of 139) with videos related to
Sort By:
Pageof 14
The Journal of Headache and Pain|May 22, 2026
Functional characterisation of dura mater αCGRP degradation fragments at vascular, immune, and CGRP receptor targetsMette N Jensen, Jens B Kristensen, Maria Castrillo, et al.Biochemistry|July 23, 2019
Pharmacological Characterization and Investigation of N-Terminal Loop Amino Acids of Adrenomedullin 2 That Are Important for Receptor ActivationHala Musa, Erica R Hendrikse, Margaret A Brimble, et al.Mayo Clinic Proceedings|January 5, 2024
Pharmacotherapies for Migraine and Translating Evidence From Bench to BedsideMessoud Ashina, Jan Hoffmann, Håkan Ashina, et al.Cell Discovery|July 28, 2016
Erratum: An allosteric role for receptor activity-modifying proteins in defining GPCR pharmacologyJoseph J Gingell, John Simms, James Barwell, et al.American Journal of Physiology. Regulatory, Integrative and Comparative Physiology|February 26, 2016
Mapping the calcitonin receptor in human brain stemRebekah L Bower, Sajedeh Eftekhari, Henry J Waldvogel, et al.Cell Discovery|July 28, 2016
An allosteric role for receptor activity-modifying proteins in defining GPCR pharmacologyJoseph J Gingell, John Simms, James Barwell, et al.British Journal of Pharmacology|October 16, 2013
Structure-activity relationships of the N-terminus of calcitonin gene-related peptide: key roles of alanine-5 and threonine-6 in receptor activationDebbie L Hay, Paul W R Harris, Renata Kowalczyk, et al.Journal of the Royal Society, Interface|December 14, 2012
Similarity between class A and class B G-protein-coupled receptors exemplified through calcitonin gene-related peptide receptor modelling and mutagenesis studiesShabana Vohra, Bruck Taddese, Alex C Conner, et al.Biochemical Pharmacology|July 15, 2017
Receptor activity-modifying protein dependent and independent activation mechanisms in the coupling of calcitonin gene-related peptide and adrenomedullin receptors to GsMichael J Woolley, Christopher A Reynolds, John Simms, et al.Biophysical Chemistry|March 7, 2024
The processing intermediate of human amylin, pro-amylin(1-48), has in vivo and in vitro bioactivityGiulia Mazzini, Christelle Le Foll, Christina N Boyle, et al.Pageof 14